HF
HRT Financial’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.3M | Buy |
+27,387
| New | +$21.3M | 0.09% | 105 |
|
2025
Q1 | – | Sell |
-8,518
| Closed | -$6.58M | – | 2754 |
|
2024
Q4 | $6.58M | Sell |
8,518
-201,491
| -96% | -$156M | 0.03% | 266 |
|
2024
Q3 | $186M | Buy |
210,009
+208,211
| +11,580% | +$184M | 0.92% | 8 |
|
2024
Q2 | $1.63M | Sell |
1,798
-14,031
| -89% | -$12.7M | 0.01% | 763 |
|
2024
Q1 | $12.3M | Sell |
15,829
-9,846
| -38% | -$7.66M | 0.08% | 123 |
|
2023
Q4 | $15M | Buy |
25,675
+12,487
| +95% | +$7.28M | 0.11% | 102 |
|
2023
Q3 | $7.08M | Buy |
13,188
+11,526
| +694% | +$6.19M | 0.07% | 175 |
|
2023
Q2 | $779K | Sell |
1,662
-324,175
| -99% | -$152M | 0.01% | 1017 |
|
2023
Q1 | $112M | Buy |
325,837
+320,334
| +5,821% | +$110M | 1.37% | 7 |
|
2022
Q4 | $2.01M | Buy |
+5,503
| New | +$2.01M | 0.03% | 565 |
|
2022
Q3 | – | Sell |
-52,549
| Closed | -$17M | – | 3021 |
|
2022
Q2 | $17M | Buy |
+52,549
| New | +$17M | 0.19% | 75 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 3211 |
|
2021
Q4 | – | Sell |
-25,229
| Closed | -$5.83M | – | 3360 |
|
2021
Q3 | $5.83M | Sell |
25,229
-31,248
| -55% | -$7.22M | 0.04% | 256 |
|
2021
Q2 | $13M | Buy |
56,477
+42,832
| +314% | +$9.83M | 0.12% | 146 |
|
2021
Q1 | $2.55M | Buy |
+13,645
| New | +$2.55M | 0.03% | 420 |
|
2020
Q4 | – | Sell |
-169,352
| Closed | -$25.1M | – | 2106 |
|
2020
Q3 | $25.1M | Buy |
+169,352
| New | +$25.1M | 0.73% | 20 |
|
2019
Q4 | – | Sell |
-3,254
| Closed | -$363K | – | 1358 |
|
2019
Q3 | $363K | Buy |
3,254
+961
| +42% | +$107K | 0.02% | 729 |
|
2019
Q2 | $254K | Buy |
+2,293
| New | +$254K | 0.02% | 562 |
|
2019
Q1 | – | Sell |
-28,290
| Closed | -$3.27M | – | 636 |
|
2018
Q4 | $3.27M | Buy |
+28,290
| New | +$3.27M | 0.47% | 40 |
|
2018
Q2 | – | Sell |
-15,748
| Closed | -$1.22M | – | 312 |
|
2018
Q1 | $1.22M | Buy |
15,748
+12,748
| +425% | +$986K | 0.58% | 37 |
|
2017
Q4 | $253K | Buy |
+3,000
| New | +$253K | 0.26% | 66 |
|